- Report
- August 2023
- 118 Pages
North America
From €1365EUR$1,500USD£1,160GBP
- Report
- June 2021
Global
From €6826EUR$7,500USD£5,798GBP
- Report
- January 2019
Global
From €6826EUR$7,500USD£5,798GBP
- Report
- May 2023
- 526 Pages
Global
From €3800EUR$4,175USD£3,228GBP
From €3186EUR$3,500USD£2,706GBP
- Report
- November 2024
- 133 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- July 2023
- 87 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- June 2023
- 122 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- July 2024
- 280 Pages
Global
From €1692EUR$1,859USD£1,437GBP
€2416EUR$2,655USD£2,052GBP
- Report
- February 2022
- 229 Pages
Global
From €2365EUR$2,598USD£2,009GBP
€3379EUR$3,712USD£2,870GBP

The Immunosorbent Assay (ELISA) market is a segment of the Diagnostics industry that focuses on the detection and quantification of antigens and antibodies in biological samples. ELISA is a laboratory technique used to detect and measure the presence of specific proteins, hormones, and other molecules in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of drugs and toxins in the body.
The ELISA market is driven by the increasing prevalence of chronic diseases, the growing demand for point-of-care testing, and the increasing demand for personalized medicine. The market is also driven by technological advancements in the field of diagnostics, such as the development of automated ELISA systems.
Some of the major companies in the ELISA market include Abbott Laboratories, Bio-Rad Laboratories, Thermo Fisher Scientific, Merck KGaA, and Roche Diagnostics. Show Less Read more